AFINITOR

Novartis AG

Application Filed: 2006-03-23

Trademark Application Details

Status

706

Live/Registered

SECTION 71 ACCEPTED

Research	OneLook Acronym Finder
Serial Number	79023992
Registration Number	3216047
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Novartis Pharmaceuticals Corporation
Attorney Name	Maury M. Tepper, III
Law Office Assigned	L40
Employee Name	LUDEMAN, JESSICA ANN

Timeline

2006-03-23	Application Filed
2006-12-19	Published for Opposition
2007-03-06	Trademark Registered
2017-05-16	Location: GENERIC WEB UPDATE
2017-05-16	Status: Live/Registered
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Novartis AG
Address	Basel CH
Legal Entity Type	Corporation
Legal Entity State	CH

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh, NC 27609

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for [ the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system, including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, ]oncology, haematology; [ ophthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungal preparations for medical use, vaccines; ]pharmaceutical preparations for medical use, namely, diagnostic purposes

Type Code

Type

GS0051

Pharmaceutical preparations for [ the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system, including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, ]oncology, haematology; [ ophthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungal preparations for medical use, vaccines; ]pharmaceutical preparations for medical use, namely, diagnostic purposes

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2006-06-29	1 REPR M:
NEW APPLICATION ENTERED IN TRAM	2006-06-30	2 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2006-09-07	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2006-09-07	4 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2006-09-08	5 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2006-09-11	6 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2006-09-11	7 RFCS P:
REFUSAL PROCESSED BY IB	2006-09-29	8 RFNT P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2006-10-02	9 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2006-10-02	10 ARAA I:Incoming Correspondence
EXAMINERS AMENDMENT -WRITTEN	2006-10-18	11 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2006-10-18	12 GNEA O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2006-10-18	13 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2006-10-19	14 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE	2006-10-20	15 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2006-10-24	16 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2006-11-29	17 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2006-12-19	18 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2007-03-06	19 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2007-09-10	20 FICR P:
FINAL DISPOSITION PROCESSED	2007-09-17	21 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2007-09-17	22 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2008-06-27	23 FINO P:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2009-06-17	24 TCCA I:Incoming Correspondence
TEAS SECTION 71 RECEIVED	2012-11-29	25 ES71 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2012-12-21	26 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED	2012-12-21	27 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2012-12-21	28 NA71 E:E-Mail
CHANGE OF NAME/ADDRESS REC'D FROM IB	2013-02-23	29 ADCH M:
NEW REPRESENTATIVE AT IB RECEIVED	2013-04-12	30 NREP P:
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED	2013-08-21	31 INPR P:
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	2014-05-22	32 INPS P:
PARTIAL INVALIDATION PROCESSED BY THE IB	2015-03-06	33 INNP P:
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	2016-03-06	34 REM4 E:E-Mail
INTERNATIONAL REGISTRATION RENEWED	2016-04-07	35 RNWL P:
TEAS SECTION 71 RECEIVED	2016-12-21	36 ES71 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2017-05-15	37 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED	2017-05-16	38 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2017-05-16	39 NA71 E:E-Mail
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED	2018-01-16	40 INPR P:
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE	2018-01-26	41 INNA R:Renewal

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
AFINITOR 79059629 3639863 Dead/Cancelled	Novartis AG 2008-09-02
AFINITOR 79023992 3216047 Live/Registered	Novartis AG 2006-03-23
AFINITOR 77675030 3785901 Dead/Cancelled	Novartis AG 2009-02-20
AFINITOR 77540495 3778903 Dead/Cancelled	Novartis AG 2008-08-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.